Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Revenue (2022 - 2025)

Historic Revenue for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $15606.0.

  • HCW Biologics' Revenue fell 9634.03% to $15606.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $422025.0, marking a year-over-year decrease of 8792.83%. This contributed to the annual value of $2.6 million for FY2024, which is 967.71% down from last year.
  • Latest data reveals that HCW Biologics reported Revenue of $15606.0 as of Q3 2025, which was down 9634.03% from $6550.0 recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Revenue registered a high of $3.1 million during Q1 2022, and its lowest value of $5065.0 during Q1 2025.
  • Over the past 4 years, HCW Biologics' median Revenue value was $618854.0 (recorded in 2024), while the average stood at $810526.5.
  • As far as peak fluctuations go, HCW Biologics' Revenue skyrocketed by 259014.16% in 2024, and later plummeted by 9955.05% in 2025.
  • HCW Biologics' Revenue (Quarter) stood at $1.3 million in 2022, then dropped by 1.31% to $1.3 million in 2023, then tumbled by 70.18% to $394804.0 in 2024, then tumbled by 96.05% to $15606.0 in 2025.
  • Its Revenue stands at $15606.0 for Q3 2025, versus $6550.0 for Q2 2025 and $5065.0 for Q1 2025.